Hemispherx BioPharma, Inc. (NYSEMKT:HEB) went lower by -1.117% to close at $ 0.177. The company exchanged total volume of 10.02 million shares throughout course of last trade however it holds an average trading capacity of 1.32 million shares. Shares of company began trading at $0.180 climbed to high of $0.219 touched the low of $0.175.
The company is trading above its 50-day moving averages of 0.145 and up from 200-day moving averages of 0.135. The firm has price to book ratio of 2.557 and its price to sale ratio was 428.450.
The average true range of Hemispherx Biopharma, Inc.’s (HEB) is recorded at 0.02 and the relative strength index of the stock stands 58.93. The stock price is going above to its 52 week low with 195.00% and lagging behind from its 52 week high with -19.40%. Analyst recommendation for this stock stands at 1.00. A look on the firm performance, its monthly performance is 47.50% and a quarterly performance of 47.50%. The stock price is trading upbeat from its 200 days moving average with 41.11% and up from 50 days moving average with 30.20%.
TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) surged +1.6359% and closed the trade at $ 0.2423. The company recorded a trading capacity of 1.68 million shares above its three months average daily volume of 845.02 thousand shares. During the last trade, shares reached to high price of $0.2800 and touched the low price of $0.2025. The stock’s 50-day moving average is noted at $0.2551 and its 200-day moving average is stands at $0.2410.
Additionally, the company has EPS of -1.7540. The company has market capitalization of $5.89M.
TetraLogic Pharmaceuticals Corporation’s (TLOG) has price-to-cash ratio of 0.70 A look on the firm performance, its monthly performance is 10.14% and a quarterly performance of -28.74%. The stock price is moving up from its 20 days moving average with 11.71% and isolated negatively from 50 days moving average with -12.06%.